A detailed history of Mutual Of America Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 177,398 shares of GILD stock, worth $16 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
177,398
Previous 179,205 1.01%
Holding current value
$16 Million
Previous $12.3 Million 20.94%
% of portfolio
0.16%
Previous 0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$66.59 - $83.99 $120,328 - $151,769
-1,807 Reduced 1.01%
177,398 $14.9 Million
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $36,627 - $42,270
580 Added 0.32%
179,205 $12.3 Million
Q1 2024

May 02, 2024

SELL
$71.58 - $87.29 $123,976 - $151,186
-1,732 Reduced 0.96%
178,625 $13.1 Million
Q4 2023

Jan 26, 2024

SELL
$73.27 - $83.09 $626,165 - $710,087
-8,546 Reduced 4.52%
180,357 $14.6 Million
Q3 2023

Nov 09, 2023

SELL
$73.94 - $80.67 $411,550 - $449,009
-5,566 Reduced 2.86%
188,903 $14.2 Million
Q2 2023

Aug 11, 2023

BUY
$76.01 - $86.7 $43,477 - $49,592
572 Added 0.3%
194,469 $15 Million
Q1 2023

May 04, 2023

SELL
$77.31 - $88.08 $95,245 - $108,514
-1,232 Reduced 0.63%
193,897 $16.1 Million
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $306,240 - $439,655
4,914 Added 2.58%
195,129 $16.8 Million
Q3 2022

Nov 08, 2022

BUY
$59.54 - $68.01 $150,517 - $171,929
2,528 Added 1.35%
190,215 $11.7 Million
Q2 2022

Aug 10, 2022

BUY
$57.72 - $65.01 $170,966 - $192,559
2,962 Added 1.6%
187,687 $11.6 Million
Q1 2022

May 02, 2022

BUY
$57.92 - $72.58 $101,881 - $127,668
1,759 Added 0.96%
184,725 $11 Million
Q4 2021

Feb 03, 2022

BUY
$64.88 - $73.64 $9,148 - $10,383
141 Added 0.08%
182,966 $13.3 Million
Q3 2021

Nov 10, 2021

BUY
$67.69 - $73.03 $55,167 - $59,519
815 Added 0.45%
182,825 $12.8 Million
Q2 2021

Aug 06, 2021

BUY
$63.47 - $69.35 $88,413 - $96,604
1,393 Added 0.77%
182,010 $12.5 Million
Q1 2021

May 13, 2021

BUY
$60.0 - $68.46 $228,360 - $260,558
3,806 Added 2.15%
180,617 $11.7 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $321,375 - $366,192
-5,673 Reduced 3.11%
176,811 $10.3 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $472,953 - $594,657
-7,616 Reduced 4.01%
182,484 $11.5 Million
Q2 2020

Aug 06, 2020

SELL
$72.34 - $84.0 $6.68 Million - $7.76 Million
-92,332 Reduced 32.69%
190,100 $14.6 Million
Q1 2020

May 11, 2020

BUY
$62.63 - $80.22 $54,300 - $69,550
867 Added 0.31%
282,432 $21.1 Million
Q4 2019

Feb 11, 2020

SELL
$61.62 - $67.78 $7,024 - $7,726
-114 Reduced 0.04%
281,565 $18.3 Million
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $2.16 Million - $2.39 Million
34,625 Added 14.02%
281,679 $17.9 Million
Q2 2019

Aug 12, 2019

BUY
$61.87 - $69.38 $235,539 - $264,129
3,807 Added 1.57%
247,054 $16.7 Million
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $507,180 - $568,175
8,111 Added 3.45%
243,247 $15.8 Million
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $858,880 - $1.12 Million
14,187 Added 6.42%
235,136 $14.7 Million
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $613,079 - $678,790
8,601 Added 4.05%
220,949 $17.1 Million
Q2 2018

Aug 09, 2018

SELL
$64.88 - $75.68 $28,287 - $32,996
-436 Reduced 0.2%
212,348 $15 Million
Q1 2018

May 11, 2018

BUY
$72.84 - $88.8 $196,886 - $240,026
2,703 Added 1.29%
212,784 $16 Million
Q4 2017

Jan 31, 2018

BUY
$71.15 - $83.52 $78,834 - $92,540
1,108 Added 0.53%
210,081 $15.1 Million
Q3 2017

Oct 18, 2017

BUY
$72.11 - $85.47 $15.1 Million - $17.9 Million
208,973
208,973 $16.9 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.